Intervention not reported
Adverse events (N)
The intervention showed no clear difference in adverse events (N) (low certainty).
1 finding from 1 review
- Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome 2019 · Cochrane Headline outcomes onlyRR 1.81 [0.83, 3.96]2 studies · 170 participantsLow